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Alveolar echinococcosis is an infectious disease caused by the larval stage of Echinococcus multilocularis. In recent years, the number of reports of alveolar echinococcosis in aberrant hosts has risen, and the disease is considered a significant problem for captive monkeys in regions where E. multilocularis is endemic. 3, 9, 6 Therefore, appropriate methods for antemortem diagnosis to allow therapeutic intervention are of great importance.
The antemortem diagnosis of alveolar echinococcosis in nonhuman primates relies on the same diagnostic tools used in humans including case history, clinical findings, identification of parasite lesions by imaging procedures, and the detection of specific serum antibodies. 3, 7 Final confirmation of the diagnosis can be done by histology and immunohistochemistry of samples as obtained by fine needle biopsy of hepatic or nonhepatic lesions. 4 reaction (PCR) analysis has been shown to be very useful. 5 Similar to other wild animals, cynomolgus monkeys (Macaca fascicularis) may show symptoms only in advanced stages of the disease. Consequently, the diagnosis of alveolar echinococcosis is often made postmortem, on the basis of distinctive macroscopic and histological findings. The diagnosis can be confirmed by immunohistochemistry or PCR analyses of affected tissues. 1 Alveolar echinococcosis was diagnosed for the first time in cynomolgus monkeys at the Zoologischer Garten Basel, Basel, Switzerland in 1994, followed by 4 other cases until 1999. 1 This disease had not been diagnosed in more than 340 cynomolgus monkeys necropsied from this colony during the past 54 years. Therefore, an investigation was initiated to assess prevalence of E. multilocularis infections among the cynomolgus monkeys.
Forty-six cynomolgus monkeys (20 males and 26 females) out of a group of 55 clinically healthy animals from the Zoologischer Garten Basel were screened. The remaining 9 monkeys were excluded because of their age. Animals were anesthetized by intramuscular injection of ketamine hydrochloride a (av- erage dose, 12 mg/kg body weight), and if needed, the immobilization was prolonged by inhalation of isofluran. b Serum samples were analyzed by enzyme-linked immunosorbent assay (ELISA) using a species-specific Em2 antigen, derived from E. multilocularis. 4 The assay was adapted for the analysis of cynomolgus sera by replacing the anti-human immunoglobulin G (IgG) with an anti-monkey IgG conjugated to alkaline phosphatase. c The assay was validated using samples from 6 cynomolgus monkeys 1 with alveolar echinococcosis, confirmed at postmortem examination and 30 sera from healthy animals. The cutoff was defined as mean absorbance of all negative sera plus 3 standard deviations. The abdominal organs of the monkeys were scanned ultrasonographically with a 7.5-MHz transducer. d Assessment of changes was done as described previously. 10 Monkeys Nos. 1, 4, 7-10 died during this study, and postmortem examinations were performed. Tissue samples were fixed in 4% buffered formalin, paraffinembedded, and cut for histological examination. Sections were stained with hematoxylin and eosin and pe-riodic acid-Schiff stain. Serum samples were tested for the presence of E. multilocularis-specific antibodies as described above. Samples of hepatic lesions, if present, were used to isolate DNA for the PCR. The primer pair BG1/BG2 specific for E. multilocularis was used as described. 5, 8 The results of serological, ultrasonographic, and postmortem examinations of all cynomolgus monkeys are summarized in Table 1 , together with the age and sex of affected monkeys. Serology with the primateadapted Em2-ELISA gave a positive result for 3 monkeys ( Nos. 1-3) . The sera of the other 43 monkeys yielded low-absorbance values, clearly below the cutoff, and were interpreted as negative for Em2. One monkey (No. 1) had multiple, small extrahepatic cysts (5-15 mm) ( Fig. 1) . At postmortem examination, 4 months later, the animal had extrahepatic (up to 2.5 cm) and intrahepatic cysts (up to 9 cm). The diagnosis of alveolar echinococcosis was confirmed by histology and PCR analyses. Monkeys Nos. 2 and 3, which were seropositive, did not show any lesions detectable by ultrasonography. However, when reexamined 10 months later, monkey No. 2 had multiple intra-and extrahepatic cysts. Both animals are still alive.
The seronegative monkey No. 4 had multiple intrahepatic cysts (5-7 mm). At postmortem examination, these cysts were identified as bile duct cysts. The ELISA remained negative at postmortem. In monkey No. 5, which was seronegative, a small cyst (5 mm) was found in the liver. Although the changes were still present in later examinations, the monkey never seroconverted and is still alive. In another seronegative monkey (No. 6), a similar lesion (3 mm) was present during the first examination but was not detectable in subsequent examinations, and the animal is still alive. Monkey No. 7, which was negative in both tests, had alveolar echinococcosis approximately 28 months later. At postmortem examination, a large, multilocular mass replaced approximately 50% of the liver and an additional mass containing remnants of pancreas and lymph node tissue was present. At death, the monkey had seroconverted. Three animals (Nos. 8-10), which were negative in both tests, died during the study, and at postmortem examination, no evidence of alveolar echinococcosis was found. Serology done after necropsy was negative in all 3 animals. All others animals (Nos. 11-46) were seronegative, had no ultrasonographically detectable changes, and are still alive.
There is a general agreement that a definitive diagnosis of alveolar echinococcosis is not possible on the basis of clinical symptoms alone. Therefore, diagnostic tools, suitable to investigate a population of animals at risk, are of major interest. This study was conducted to assess the prevalence of alveolar echinococcosis in a colony of M. fascicularis, which had previously experienced loss of some animals because of E. multilocularis.
Earlier studies have shown high levels of antibodies against Em2 in cynomolgus monkeys that died of alveolar echinococcosis or were euthanatized during late stages of the disease. 1 It was, therefore, assumed that serology may be a useful test to identify monkeys at risk of developing alveolar echinococcosis. However, the number of positive animals in the colony was much lower than expected, and because euthanasia is not an option, the disease status of seropositive monkeys Nos. 2 and 3 cannot be determined at the moment. Presence of antibodies against E. multilocularis without concurrent overt disease has been reported in humans. 7, 11 This is possibly the case in the 2 cynomolgus monkeys, which were serologically positive but have not developed clinically apparent disease so far. The additional use of ultrasonographic examination did not help in reaching an unambiguous diagnosis in these 2 animals. Although 1 monkey had cystic structures in the liver at a later time suggestive of metacestodal tissue, it is still alive. Either this animal is very successful in controlling the disease or the cysts are of a different origin similar to those in monkey No. 4. Several differential diagnoses must be considered for cystic lesions in abdominal organs consistent with alveolar echinococcosis. 2, 6 These include cysts of inflammatory or congenital origin, cystic neoplasms, or dilated bile ducts. 13 So far, more than 2 years after the initial study, none of the other animals with such suggestive ultrasonographic changes and with a negative serology developed alveolar echinococcosis. Although the disease may still develop, the animals remain seronegative and are considered not to be infected with E. multilocularis.
The findings of this study show that serology may be a useful method to screen a primate colony for alveolar echinococcosis and may give a reasonable indication of past exposure. However, because of the lack of knowledge regarding the course of development of lesions in cynomolgus monkeys, only limited predictions, even with additional ultrasonographic examinations, seem to be possible regarding future disease progression. However, the possibility of rapid disease development as seen in monkeys Nos. 1 and 7 underscores the necessity for regular screening. Correct diagnosis is essential for adequate therapy. Small and well-demarcated lesions can be removed surgically followed by postsurgery chemotherapy with mebendazole or albendazole. 10 These drugs may also be indicated as parasitistatic for a long-time chemotherapy, if the lesions are extensive. This study shows the potential need for further invasive, potentially risky diagnostic methods, such as histopathological evaluation of a biopsy, before initiating costly treatment.
